| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.760 | 37.249 | 34.953 | 2.604 | 601 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 28.756 | 41.233 | 40.064 | 7.976 | 16.757 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 23.251 | 25.206 | 23.076 | 4.698 | 99.094 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 5.505 | 16.027 | 16.988 | 3.278 | -82.337 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 4.762 | 15.588 | 16.431 | 3.027 | -82.846 | 0 | 0 | 0 | 0 | 0 |
| Employees | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Paxmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 119.502 | 113.372 | 107.197 | 101.051 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 39.837 | 53.419 | 73.946 | 76.805 | 60.918 | 59.763 | 58.438 | 58.619 | 50.449 | 50.374 |
| Inventories | 1.248 | 1.240 | 1.364 | 1.339 | 1.313 | 1.289 | 1.260 | 1.264 | 1.260 | 1.253 |
| Receivables | 34.589 | 36.070 | 34.945 | 39.211 | 38.452 | 37.723 | 36.887 | 37.001 | 36.946 | 36.946 |
| Cash | 4.000 | 16.110 | 37.637 | 36.255 | 21.152 | 20.751 | 20.291 | 20.354 | 12.243 | 12.175 |
| Shareholders Funds | 35.760 | 50.983 | 66.551 | 68.356 | -15.813 | -15.513 | -15.169 | -15.216 | -15.170 | -15.086 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 48.926 | 116.069 | 43.567 | 39.779 | 8.360 | 8.201 | 8.019 | 8.044 | 28 | 0 |
| Income in Advance | 74.917 | 72.508 | 71.281 | 69.973 | 68.618 | 67.317 | 65.824 | 66.028 | 65.828 | 65.460 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Paxmed S.r.l.